ATE316376T1 - Neue pharmazeutische zusammenstellung und deren herstellungsprozess - Google Patents

Neue pharmazeutische zusammenstellung und deren herstellungsprozess

Info

Publication number
ATE316376T1
ATE316376T1 AT99972919T AT99972919T ATE316376T1 AT E316376 T1 ATE316376 T1 AT E316376T1 AT 99972919 T AT99972919 T AT 99972919T AT 99972919 T AT99972919 T AT 99972919T AT E316376 T1 ATE316376 T1 AT E316376T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
manufacturing process
new pharmaceutical
methyl
new
Prior art date
Application number
AT99972919T
Other languages
German (de)
English (en)
Inventor
Helle Weibel
Thyge Borup Hjorth
Original Assignee
Reddy Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy Research Foundation filed Critical Reddy Research Foundation
Application granted granted Critical
Publication of ATE316376T1 publication Critical patent/ATE316376T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99972919T 1998-12-01 1999-11-29 Neue pharmazeutische zusammenstellung und deren herstellungsprozess ATE316376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199801580 1998-12-01

Publications (1)

Publication Number Publication Date
ATE316376T1 true ATE316376T1 (de) 2006-02-15

Family

ID=8106261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972919T ATE316376T1 (de) 1998-12-01 1999-11-29 Neue pharmazeutische zusammenstellung und deren herstellungsprozess

Country Status (21)

Country Link
US (1) US7439248B1 (fr)
EP (1) EP1135127B1 (fr)
JP (2) JP5524435B2 (fr)
KR (1) KR100690311B1 (fr)
CN (1) CN1158075C (fr)
AT (1) ATE316376T1 (fr)
AU (1) AU776299B2 (fr)
BR (1) BR9915835A (fr)
CA (1) CA2352430C (fr)
CZ (1) CZ300543B6 (fr)
DE (1) DE69929635T2 (fr)
ES (1) ES2257886T3 (fr)
HU (1) HUP0104544A3 (fr)
IL (3) IL143299A0 (fr)
NO (1) NO329909B1 (fr)
PL (1) PL197077B1 (fr)
RU (1) RU2233659C2 (fr)
TW (1) TWI235657B (fr)
UA (1) UA75569C2 (fr)
WO (1) WO2000032191A1 (fr)
ZA (1) ZA200104261B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2352430C (fr) * 1998-12-01 2008-11-18 Novo Nordisk A/S Nouvelle composition pharmaceutique et procede de preparation
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
WO2001089523A1 (fr) 2000-05-26 2001-11-29 Novo Nordisk A/S Nouvelle composition pharmaceutique et son procede de preparation
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2003051355A1 (fr) * 2001-12-19 2003-06-26 Takeda Chemical Industries, Ltd. Compositions solides refermant des composes instables a l'oxygene et procede de stabilisation de ces composes
WO2004106416A1 (fr) * 2003-05-30 2004-12-09 Asahi Kasei Chemicals Corporation Poudre de cellulose
WO2006002255A2 (fr) * 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. Preparation pharmaceutique de balaglitazone
CL2008000596A1 (es) * 2007-03-01 2008-09-05 Glaxo Group Ltd Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280997A (en) * 1978-12-08 1981-07-28 Johannes Van Leverink Extrusion process for the preparation of anhydrous stable lactose
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
CA2019324C (fr) * 1989-07-10 1996-08-20 Robert L. Jerzewski Comprimes de fosinopril
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
IT1238072B (it) * 1990-01-19 1993-07-03 Sclavo Spa Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
SK121193A3 (en) * 1991-04-04 1994-07-06 Procter & Gamble Chewable antacid compositions
SK117793A3 (en) * 1991-04-29 1994-05-11 Merck & Co Inc Optimized tablet formulation
TW245716B (fr) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
TW268952B (fr) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
AU668818B2 (en) * 1993-04-07 1996-05-16 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivative and pharmaceutical composition containing the same
US5882681A (en) * 1993-09-03 1999-03-16 Smithkline Beecham Corporation Stabilized tablet formulation
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5532256A (en) 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
EP1057479A1 (fr) * 1994-12-14 2000-12-06 Enbalt Trading Limited Formulations de comprimes pharmaceutiques elabores par compression directe
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
JPH09249561A (ja) * 1996-03-15 1997-09-22 Teikoku Chem Ind Corp Ltd 医薬組成物
HU222109B1 (hu) * 1996-09-10 2003-04-28 EGIS Gyógyszergyár Rt. Captopriltartalmú tabletták és eljárás ezek előállítására
ES2199366T3 (es) * 1996-12-31 2004-02-16 Dr. Reddy's Laboratories Ltd. Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen y su uso en el tratamiento de diabetes y enfermedades relacionadas.
AU7109798A (en) 1997-12-02 1998-10-30 Dr. Reddy's Research Foundation Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypol ipidemia and antihypertensive properties
EP0945134A1 (fr) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Nouvelles formes galeniques du meloxicam pour administration par voie orale
CA2352430C (fr) * 1998-12-01 2008-11-18 Novo Nordisk A/S Nouvelle composition pharmaceutique et procede de preparation
WO2001089523A1 (fr) * 2000-05-26 2001-11-29 Novo Nordisk A/S Nouvelle composition pharmaceutique et son procede de preparation
WO2006002255A2 (fr) 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. Preparation pharmaceutique de balaglitazone

Also Published As

Publication number Publication date
US7439248B1 (en) 2008-10-21
EP1135127A1 (fr) 2001-09-26
JP2002531404A (ja) 2002-09-24
IL179865A (en) 2009-12-24
PL197077B1 (pl) 2008-02-29
IL143299A0 (en) 2002-04-21
JP2012144560A (ja) 2012-08-02
HUP0104544A2 (en) 2002-08-28
NO329909B1 (no) 2011-01-24
WO2000032191A1 (fr) 2000-06-08
TWI235657B (en) 2005-07-11
AU1376200A (en) 2000-06-19
KR100690311B1 (ko) 2007-03-09
CN1158075C (zh) 2004-07-21
EP1135127B1 (fr) 2006-01-25
AU776299B2 (en) 2004-09-02
HUP0104544A3 (en) 2003-12-29
NO20012673D0 (no) 2001-05-31
RU2233659C2 (ru) 2004-08-10
KR20010099827A (ko) 2001-11-09
IL143299A (en) 2006-12-31
PL348601A1 (en) 2002-06-03
DE69929635T2 (de) 2006-09-21
CA2352430C (fr) 2008-11-18
NO20012673L (no) 2001-05-31
ES2257886T3 (es) 2006-08-01
ZA200104261B (en) 2002-05-24
CZ20011832A3 (cs) 2001-10-17
JP5524435B2 (ja) 2014-06-18
IL179865A0 (en) 2007-05-15
DE69929635D1 (de) 2006-04-13
BR9915835A (pt) 2001-08-21
CN1356901A (zh) 2002-07-03
UA75569C2 (en) 2006-05-15
CA2352430A1 (fr) 2000-06-08
CZ300543B6 (cs) 2009-06-10

Similar Documents

Publication Publication Date Title
EE200100594A (et) Uudsed ravimikompositsioonid, mis põhinevad antikolinergiliselt toimivatel ühenditel ja ß-mimeetikumidel
WO2000017190A3 (fr) Derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EE05107B1 (et) Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning ühendi kasutamine
BR9906904B1 (pt) composto bicìclico heteroaromático como inibidor de tirosina quinase de proteìna, formulação farmacêutica compreendendo o mesmo, e seu uso.
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
BR9814592B1 (pt) composto azapolicìclico condensado com arila, composição farmacêutica contendo o mesmo e seu uso na fabricação de um medicamento.
ATE312613T1 (de) Niedrig dosierte entecavir formulierung und deren verwendung
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
BR0014526B1 (pt) compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo
FI19991852L (fi) Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
HUP0204101A3 (en) 3-aminoquinazolin-2,4-dione antibacterial agents, pharmaceutical compositions containing them and their use
DE69907977D1 (de) Pyrrolobenzodiazepine
PL366851A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU2002333373A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
EE200200617A (et) (Tio)karbamiidi derivaat, seda sisaldav farmatseutiline preparaat, selle valmistamine ning kasutamine VIIa-teguri inhibiitorina
EE200200342A (et) Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
ATE316376T1 (de) Neue pharmazeutische zusammenstellung und deren herstellungsprozess
ES2193007T1 (es) Formulacion farmaceutica estable que comprende la modificacion ii de torsemida.
DE60121293D1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
DE60100634D1 (de) Optisch-aktive Phosphatverbindung und deren Verwendung
IT8922398A0 (it) Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
AU2001262467A1 (en) Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
ITRM20000432A0 (it) Pirrolo [2,1-b] [1,3] benzotiazepine e loro uso per la preparazione di medicamenti ad attivita' antipsicotica classica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties